26th Nov 2010 15:56
Verona Pharma, respiratory diseases treatment developer, is initiating a new higher dose trial of its lead drug, RPL554, in patients with asthma, after receiving the go-ahead from the Dutch authorities. The company also announced that it has completed proof of concept trials on delivering RPL554 vi
Read more14th Jul 2010 14:03
LONDON (Dow Jones)--PHSC PLC (PHSC.LN), a health, safety, asbestos, hygiene and environmental consultancy company, announced Wednesday it made a 6% rise in its pretax profit to GBP500,000 for the year ended March 31, compared with GBP472,000. MAIN FACTS: -Group revenues at GBP4.922 million (
Read more30th Nov 2009 07:37
SDI swung into the black at the half-way stage, although the automated warehousing systems firm said the outlook remains "tough". There was a profit of £305,000 in the six months to 30 September versus a loss of £2.6m in the half year to 31 May 2008 (the year end has now moved from November to Marc
Read more